

Author: Sultana Shaheen Talegaonkar Sushma Ali Rashid Mittal Gaurav Ahmad Farhan Jalees Bhatnagar Aseem
Publisher: Informa Healthcare
ISSN: 1464-5246
Source: Journal of Microencapsulation, Vol.29, Iss.5, 2012-08, pp. : 445-454
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The precipitation technique was used to prepare non-polymeric alendronate nanoparticles. The influence of various formulation parameters on the average particle size was investigated and the effect of various stabilizers (PVA, tween, chitosan, alginate, PEG, HPMC, poloxomers) was evaluated. The selection of surfactant was a key factor to produce particles with desired properties. Poloxomer F68 was found best in achieving the minimum particle size and providing physical stability to the drug. On basis of preliminary trials, a central composite design was employed to study the effect of independent variables, drug concentration (
Related content


Alendronate plus cholecalciferol for the treatment of osteoporosis
Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. :


Which Dry Powder Inhaler Should Be Chosen?
Respiration, Vol. 78, Iss. 3, 2009-07 ,pp. :


Duaklir Genuair, the latest dry powder inhaler for COPD
PRESCRIBER, Vol. 26, Iss. 12, 2015-06 ,pp. :




Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol
By Pavkov Richard Mueller Stefan Fiebich Katrin Singh Dilraj Stowasser Frank Pignatelli Giovanni Walter Benoît Ziegler Dominik Dalvi Mukul Dederichs Juergen Rietveld Ilse
Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. :